Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism

European Journal of Endocrinology

Volumn 147, Issue 5, 2002, Pages 671-675

  Correa, Pamela ^a   Åkerström, Göran ^a   Westin, Gunnar ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PARATHYROID HORMONE; TRANSCRIPTION FACTOR; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; CALCIUM HOMEOSTASIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEEDBACK SYSTEM; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MALE; PARATHYROID ADENOMA; PARATHYROID CELL; PARATHYROID GLAND; PARATHYROID HORMONE RELEASE; PARATHYROID HYPERPLASIA; PARATHYROID TUMOR; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY HYPERPARATHYROIDISM; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 0036856369     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470671     Document Type: Article

References (20)

1. Arnold A, Staunton CE, Kim HG, Gaz RD & Kronenberg HM. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. New England Journal of Medicine 1988 318 658-662.
2. Shan L, Nakamura M, Nakamura Y, Inoue D, Morimoto S, Yokoi T et al. Comparative analysis of clonality and pathology in primary and secondary hyperparathyroidism. Virchows Archives 1997 430 247-251.
3. Lundgren E, Rastad J, Thurfjell E, Åkerström G & Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormones values in menopausal women. Surgery 1997 121 287-294.
4. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. Journal of Bone and Mineral Research 1998 13 325-349.
5. Jones G, Strugnell SA & DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiological Reviews 1998 78 1193-1231.
6. Hellman P, Liu W, Westin G, Törmä H & Åkerström G. Vitamin D and retinoids in parathyroid glands (review). International Journal of Molecular Medicine 1999 3 355-361.
7. Silver J, Yalcindag C, Sela-Brown A, Kilav R & Naveh-Many T. Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney International 1999 73 (Suppl) S2-S7.
8. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. Journal of Clinical Investigation 1999 92 1436-1443.
9. Carling T, Rastad J, Szabo E, Westin G & Åkerström G. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2000 85 2000-2003.
10. Sudhaker Rao D, Han ZH, Phillips ER, Palnitkar S & Parfitt AM. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis. Clinical Endocrinology 2000 53 373-381.
11. Carling T, Kindmark A, Hellman P, Holmberg L, Åkerström G & Rastad J. Vitamin D receptor alleles b, a, and T: risk factors for sporadic primary hyperparathyroidism (HPT) but not of uremia or MEN 1. Biochemical and Biophysical Research Communications 1997 231 329-332.
12. Carling T. Rastad J, Åkerstrom G & Westin G. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. Journal of Clinical Endocrinology and Metabolism 1988 83 2255-2259.
13. Yoshizawa T, Honda Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nature Genetics 1997 16 391-396.
14. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. PNAS 1988 85 3294-3298.
15. Miyamoto K, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E, Tatsumi S et al. Structural organization of the human vitamin receptor chromosomal gene and its promoter. Molecular Endocrinology 1997 11 1165-1179.
16. Crofts LA, Hancock MS, Morrison NA & Eisman JA. Multiple promoters direct the tussue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. PNAS 1998 95 10529-10534.
17. Byrne IM, Flanagan L, Tenniswood MP & Welsh J. Identification of a homone-responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene. Endocrinology 2000 141 2829-2836.
18. Sunn KL, Cock T-A, Crofts LA, Eisman JA & Gardiner EM. Novel N-terminal variant of human VDR. Molecular Endocrinology 2001 15 1599-1609.
19. Gibson UE, Heid CA & Williams PM. A novel method for real time quantitative RT-PCR. Genome Research 1996 6 995-1001.
20. Rao DS, Honasoge M, Divine GW, Phillips ER, Lee MW, Ansari MR et al. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. Journal of Clinical Endocrinology and Metabolism 2000 85 1054-1058.